Bünyamin Bulkurcucoğlu

Dr. Bünyamin Bulkurcucoğlu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Nano Today
Verified
Journal Article
Closed access
ABAyça Bal-Ozturk
Ayça Bal-Ozturk
BCBerivan Cecen
Berivan Cecen
Meltem Avci-AdaliMeltem Avci-Adali
Meltem Avci-Adali
STSeda Nur Topkaya
Seda Nur Topkaya
EAEmine Alarcin
Emine Alarcin
Shabir HassanShabir Hassan
Shabir Hassan

11 March 2024 in ChemistryOpen
Verified
Journal Article
Open access
SESebnem Ercelen
Sebnem Ercelen
BBBünyamin Bulkurcucoğlu
Bünyamin Bulkurcucoğlu
MOMustafa Oksuz
Mustafa Oksuz
ANAyse Nalbantsoy
Ayse Nalbantsoy
NSNazli Sarikahya
Nazli Sarikahya
Saponins are glycosides widely distributed in the plant kingdom and have many pharmacological activities. However, their tendency to bind to cell membranes can cause cell rupture, limiting their clinical use. In the previous study, aristatoside C and davisianoside B were isolated from Cephalaria species. Cytotoxicity assays showed that they are more active on A‐549 cell lines than doxorubicin but caused hemolysis. In the current research, aristatoside C and davisianoside B were loaded to phytosomes called ALPs and DLPs respectively, and characterized for particle size, zeta potential, encapsulation efficiency, release kinetic, hemolytic activity, and cytotoxicity on A‐549 cell line. DLPs maintained the cytotoxic activity of the free saponins against A‐549 cells with IC50 of 9,64±0,02 μg/ml but dramatically reduced their hemolytic activity. Furthermore, temperature and time‐dependent stability studies based on the size and zeta potential of ALPs and DLPs revealed that the phytosomes have sustained release properties over 2 weeks. Overall, DLPs displayed cytotoxicity against A‐549 cells with minimal hemolysis and sustained release, highlighting their potential as nanotherapeutics for clinical applications.

17 November 2024 in Biotechnology Journal
Verified
Journal Article
Open access
BBBünyamin Bulkurcucoğlu
Bünyamin Bulkurcucoğlu
MGMustafa Ulvi Gürbüz
Mustafa Ulvi Gürbüz
STSilvia Tyciakova
Silvia Tyciakova
KPKristina Pavlov
Kristina Pavlov
NMNikoleta Mojzesova
Nikoleta Mojzesova
SESebnem Ercelen
Sebnem Ercelen
A promising approach to treat colorectal cancer (CRC) involves combining chemotherapy, epigenetics, and gene therapy to combat drug resistance. Multifunctional nanocarriers have emerged as a valuable tool for targeted CRC therapy. By delivering multiple treatments directly to cancer cells, these nanocarriers offer the potential for improved outcomes and reduced side effects. PAMAM‐based dendrimers were functionalized with a unique combination of folic acid, 5‐FU, SAHA, and plasmid DNA pCIneoGFP for targeted delivery to CRC cells. Biophysical characterizations of therapeutic loaded dendrimers and their complexes with pCIneoGFP were performed by: dynamic light scattering, fluorescence spectroscopy, and gel electrophoresis. Further, cellular analyses of dendriplexes demonstrated high transfection efficiency and anticancer activity on HCT 116 and HT‐29 cell lines. We have successfully developed a multifunctional nanocarrier platform based on PAMAM dendrimers, offering a promising tool for targeted combination therapy of CRC.

31 July 2026 in Gels
Verified
Journal Article
Open access
PDF file
SESebnem Ercelen
Sebnem Ercelen
Natalia MitinaNatalia Mitina
Natalia Mitina
Nataliya FiniukNataliya Finiuk
Nataliya Finiuk
BBBünyamin Bulkurcucoğlu
Bünyamin Bulkurcucoğlu
SSSaygin San
Saygin San
AZAlexander Zaichenko
Alexander Zaichenko
Novel anionic cross-linked hydrogel-based microparticles with controlled size, functionality, porosity, and morphology were synthesized via tailored precipitation polymerization of hydrophobic and hydrophilic monomers in the presence of dimethacrylate as a cross-linking agent. The resulting hydrogel microparticles (HG5), with a size of 250 ± 50 nm and a polydispersity index of 0.079, were readily dispersible in water and formed stable suspensions at physiological pH (7.2–7.4). Their physicochemical properties were comprehensively characterized using FT-IR, NMR, DLS, SAXS, TEM, and turbidimetry. HG5 efficiently incorporated albumin as a model antigen with a loading efficiency of 95%, forming stable hydrogel–protein complexes that maintained their hydrodynamic size and colloidal stability over one month of storage. Biological evaluation demonstrated low toxicity toward pseudonormal cell lines, with cell viability remaining above 50% at concentrations up to 5 mg/mL and no detectable apoptotic effects in HEK293 cells. Human peripheral blood mononuclear cells (PBMCs) were sensitive to HG5 exposure, exhibiting an IC50 of 0.52 mg/mL, while showing good hemocompatibility with hemolysis below 5%. HG5 significantly enhanced immunogenicity, increasing BSA-specific antibody levels by 1.9-fold compared to the immunization without adjuvant (p < 0.05). These findings demonstrate the potential of HG5 as a versatile platform for protein delivery and vaccine adjuvant development.